Study endpoint
The study endpoint was the safety outcomes including thromboembolic events and bleeding complications during the procedure and 30 days following CBA. Thromboembolism was diagnosed by a combination of both the clinical situation and radiologic studies. Thromboembolic events were defined as stroke, transient ischemic attack (TIA), or systemic embolism (SE). Bleeding complications were defined as any procedure-related bleeding.